Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial.
Wang L, Sun M, Li J, Wan L, Tan Y, Tian S, Hou Y, Wu L, Peng Z, Hu X, Zhang Q, Huang Z, Han M, Peng S, Pan Y, Ren Y, Zhang M, Chen D, Liu Q, Li X, Qin ZY, Xiang J, Li M, Zhu J, Chen Q, Luo H, Wang S, Wang T, Li F, Bian XW, Wang B.
Wang L, et al. Among authors: qin zy.
Clin Cancer Res. 2025 Jan 6;31(1):74-86. doi: 10.1158/1078-0432.CCR-24-2436.
Clin Cancer Res. 2025.
PMID: 39495175
Clinical Trial.